drugset
drugset / Trial / NCT00059358

Zidovudine Levels in HIV Infected Patients Being Treated for HCV

NCT00059358 ↗

Phase 1/2 Completed 16 enrolled National Institute of Allergy and Infectious Diseases (NIAID)
Non-randomizedSingle-groupOpen-labelTreatment

Summary

This study will test the amount of anti-HIV drugs in the blood cells of HIV-infected patients who are also being treated for hepatitis C virus (HCV) infection.

Timeline

Start
2001-09
Primary completion
2005-06
Completion
2005-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Peginterferon alfa-2b Protein / enzyme biologic — Subcutaneous
Subject Ribavirin Small molecule — Oral
Subject interferon alfa-2b Protein / enzyme biologic — —

Indications

HIV infectious disease hepatitis C virus infection